| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jessica L Beers, Aurora K Authement, Nina Isoherranen, Klarissa D Jackso. Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol. ACS medicinal chemistry letters. vol 14. issue 5. 2023-05-17. PMID:37197460. |
the cannabinoids cannabidiol (cbd) and delta-9-tetrahydrocannabinol (thc) undergo extensive oxidative metabolism in the liver. |
2023-05-17 |
2023-08-14 |
Not clear |
| Mariana Babayeva, Zvi G Loew. Cannabis Pharmacogenomics: A Path to Personalized Medicine. Current issues in molecular biology. vol 45. issue 4. 2023-05-16. PMID:37185752. |
this review classifies the current knowledge of pharmacogenomics associated with medical marijuana and related compounds and can assist in improving the outcomes of cannabinoid therapy and to minimize the adverse effects of cannabis use. |
2023-05-16 |
2023-08-14 |
Not clear |
| Daphna T Katz, Amanda Fifi, Alessandra Milesi-Halle, Miguel Sap. A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy. JPGN reports. vol 4. issue 1. 2023-05-15. PMID:37181918. |
a rare case of cannabinoid hyperemesis syndrome secondary to cannabidiol for refractory epilepsy. |
2023-05-15 |
2023-08-14 |
Not clear |
| Daphna T Katz, Amanda Fifi, Alessandra Milesi-Halle, Miguel Sap. A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy. JPGN reports. vol 4. issue 1. 2023-05-15. PMID:37181918. |
cannabinoid hyperemesis syndrome (chs) is associated with tetrahydrocannabinol, and rarely has been reported with cannabidiol. |
2023-05-15 |
2023-08-14 |
Not clear |
| Daphna T Katz, Amanda Fifi, Alessandra Milesi-Halle, Miguel Sap. A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy. JPGN reports. vol 4. issue 1. 2023-05-15. PMID:37181918. |
we review the mechanism by which cannabidiol is believed to reduce seizures and be both anti- and pro-emetic, mainly through interactions with cannabinoid receptors and transient receptor channels. |
2023-05-15 |
2023-08-14 |
Not clear |
| Xiangping Su. Research Progress on Cannabinoids in Molecules (Basel, Switzerland). vol 28. issue 9. 2023-05-14. PMID:37175216. |
research progress on cannabinoids in cannabis ( |
2023-05-14 |
2023-08-14 |
Not clear |
| Zahraa Haidar, Hussein Traboulsi, David H Eidelman, Carolyn J Baglol. Differential inflammatory profile in the lungs of mice exposed to cannabis smoke with varying THC:CBD ratio. Archives of toxicology. 2023-05-14. PMID:37179517. |
cannabis contains cannabinoids including Δ |
2023-05-14 |
2023-08-14 |
mouse |
| Narumon Changsan, Somchai Sawatdee, Roongnapa Suedee, Charisopon Chunhachaichana, Teerapol Srichan. Aqueous cannabidiol β-cyclodextrin complexed polymeric micelle nasal spray to attenuate in vitro and ex-vivo SARS-CoV-2-induced cytokine storms. International journal of pharmaceutics. 2023-05-14. PMID:37182795. |
cannabidiol (cbd) has a number of biological effects by acting on the cannabinoid receptors cb |
2023-05-14 |
2023-08-14 |
Not clear |
| Deepak Cyril D'Souz. Cannabis, cannabinoids and psychosis: a balanced view. World psychiatry : official journal of the World Psychiatric Association (WPA). vol 22. issue 2. 2023-05-10. PMID:37159370. |
cannabis, cannabinoids and psychosis: a balanced view. |
2023-05-10 |
2023-08-14 |
Not clear |
| Chaobiao Yan, Yu Li, Hanqing Liu, Diyu Chen, Jian W. Antitumor mechanism of cannabidiol hidden behind cancer hallmarks. Biochimica et biophysica acta. Reviews on cancer. 2023-05-10. PMID:37164234. |
as the primary ingredient in exogenous cannabinoids, cannabidiol (cbd) has drawn a lot of interest from researchers due to its negligible psychotropic side effects and potential tumor-suppressing properties. |
2023-05-10 |
2023-08-14 |
Not clear |
| Mauro Maccarrone, Vincenzo Di Marzo, Juerg Gertsch, Uwe Grether, Allyn C Howlett, Tian Hua, Alexandros Makriyannis, Daniele Piomelli, Natsuo Ueda, Mario van der Stel. Pharmacological reviews. 2023-05-10. PMID:37164640. |
compelling research evidence and the fda cannabis-derived cannabidiol approval for severe childhood epilepsy have confirmed the large therapeutic potential of cannabidiol itself, Δ9-tetrahydrocannabinol (thc) and other plant-derived cannabinoids (phytocannabinoids). |
2023-05-10 |
2023-08-14 |
human |
| Priya Gupta, Archu Singh, Sadat Shafi, Tanya Ralli, Faheem Hyder Pottoo, Yasmin Sultana, Kanchan Kohl. Cannabis Sativa in Phytotherapy: Reappraisal of Therapeutic Potential and Regulatory Aspects. Current pharmaceutical biotechnology. 2023-05-09. PMID:37157219. |
cannabis sativa is widely used as a folk medicine in many parts of the globe and has been reported to be a treasure trove of phytoconstituents, including cannabinoids, terpenoids, and flavonoids. |
2023-05-09 |
2023-08-14 |
Not clear |
| Priya Gupta, Archu Singh, Sadat Shafi, Tanya Ralli, Faheem Hyder Pottoo, Yasmin Sultana, Kanchan Kohl. Cannabis Sativa in Phytotherapy: Reappraisal of Therapeutic Potential and Regulatory Aspects. Current pharmaceutical biotechnology. 2023-05-09. PMID:37157219. |
in the past two decades, extensive research on cannabis has led to a resurgence of interest in the clinical application of its constituents, particularly cannabinoids. |
2023-05-09 |
2023-08-14 |
Not clear |
| Martina Franzin, Rachele Ruoso, Rossella Del Savio, Eugenia Akhavan Niaki, Aba Pettinelli, Giuliana Decorti, Gabriele Stocco, Riccardo Addobbat. Quantification of 7 cannabinoids in cannabis oil using GC-MS: Method development, validation and application to therapeutic preparations in Friuli Venezia Giulia region, Italy. Heliyon. vol 9. issue 4. 2023-05-08. PMID:37151683. |
quantification of 7 cannabinoids in cannabis oil using gc-ms: method development, validation and application to therapeutic preparations in friuli venezia giulia region, italy. |
2023-05-08 |
2023-08-14 |
Not clear |
| Caitlin Wei-Ming Watson, Erin Sundermann, Jonathan Helm, Emily W Paolillo, Suzi Hong, Ronald J Ellis, Scott Letendre, Thomas D Marcotte, Robert K Heaton, Erin E Morgan, Igor Gran. A longitudinal study of cannabis use and risk for cognitive and functional decline among older adults with HIV. AIDS and behavior. 2023-05-08. PMID:37155086. |
to inform safe and efficacious medical cannabis use, the effects of specific cannabinoid doses on cognition and biological mechanisms must be investigated in older adults. |
2023-05-08 |
2023-08-14 |
human |
| Melissa Pulkoski, Hannah Burrac. Assessing the impact of piercing-sucking pests on greenhouse-grown industrial hemp (Cannabis sativa L.). Environmental entomology. 2023-05-08. PMID:37156240. |
we sought to understand the effects of feeding by t. urticae and myzus persicae (green peach aphid), as a proxy for p. cannabis, on the concentration of economically significant cannabinoids through a series of experiments on greenhouse grown plants. |
2023-05-08 |
2023-08-14 |
spider |
| Beth M Wiese, Angelica Alvarez Reyes, Todd W Vanderah, Tally M Largent-Milne. The endocannabinoid system and breathing. Frontiers in neuroscience. vol 17. 2023-05-05. PMID:37144090. |
recent changes in cannabis accessibility have provided adjunct therapies for patients across numerous disease states and highlights the urgency in understanding how cannabinoids and the endocannabinoid (ec) system interact with other physiological structures. |
2023-05-05 |
2023-08-14 |
Not clear |
| Jared S Wood, William H Gordon, Jeremy B Morgan, R Thomas Williamso. Cannabicitran: Its unexpected racemic nature and potential origins. Chirality. 2023-05-04. PMID:37142400. |
cannabicitran is a cannabinoid found in levels up to ~10% in commercial "purified" cannabidiol (cbd) extracts. |
2023-05-04 |
2023-08-14 |
Not clear |
| Sumit S Rathod, Yogeeta O Agrawa. Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer's Disease. Current drug research reviews. 2023-05-03. PMID:37132109. |
in this review, we emphasize several plant-derived cannabinoids such as β-caryophyllene (bcp), cannabichromene (cbc), cannabigerol (cbg), cannabidiol (cbd), and cannabinol (cbn), which are known to have distinctive modulation abilities of ecs. |
2023-05-03 |
2023-08-14 |
Not clear |
| Tereza Buchtova, Lucie Beresova, Katarina Chroma, Tomas Pluhacek, Tibor Beres, Dominika Kaczorova, Petr Tarkowski, Jiri Bartek, Martin Mistri. Cannabis-derived products antagonize platinum drugs by altered cellular transport. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. vol 163. 2023-05-03. PMID:37137184. |
cannabinoids, a class of compounds derived from cannabis sativa l., have recently become more widely accessible for public consumption in the form of diverse cannabis products, in parallel with weakening the measures that so far restricted their availability. |
2023-05-03 |
2023-08-14 |
human |